Stock ORX OREXO AB
Add to a list
To use this feature you must be a member
Log inSign up

News Orexo AB

Equities

ORX

SE0000736415

Delayed Nasdaq Stockholm
Other stock markets
 09:30:32 2024-04-24 am EDT 		5-day change 1st Jan Change
17.18 SEK +3.62% Intraday chart for Orexo AB -1.83% +11.13%
Apr. 17 Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment MT
Apr. 17 Orexo Extends Patent Protection for Its Nasal Epinephrine Powder Product OX640 in the US CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment
MT
Orexo extends patent protection for its nasal epinephrine powder product OX640 in the US
AQ
Orexo Extends Patent Protection for Its Nasal Epinephrine Powder Product OX640 in the US
CI
Sweden's Orexo Set for Early Redemption of Bonds Due 2025
MT
Orexo announces that the condition for early redemption of its existing bonds has been fulfilled
AQ
Orexo publishes the Annual and Sustainability Report for 2023
AQ
Orexo AB Announces Board Resignations
CI
Correction: Notice of Annual General Meeting of Orexo
AQ
Notice of Annual General Meeting of Orexo
AQ
Orexo Issues SEK500 Million Social Bonds, Closes Tender Offer
MT
Orexo Issues Senior Secured Callable Floating Rate Social Bonds of SEK 500 Million and Announces Results of the Tender Offer for Its Existing Bonds
CI
Orexo successfully issues senior secured callable floating rate social bonds of SEK 500 m and announces results of the tender offer for its existing bonds
AQ
Orexo Plans SEK500 Million New Social Bond Issuance, Tender Offer
MT
Orexo contemplates issuance of senior secured callable floating rate social bonds and announces a conditional tender offer for its existing bonds
AQ
Orexo strengthens its sustainability work by establishing a social financing framework
AQ
Orexo, Swedish Orphan Biovitrum to Further Explore AmorphOX Combination
MT
Orexo and Sobi agree to advance feasibility study with AmorphOX
AQ
Orexo AB (Publ.) and Swedish Orphan Biovitrum AB (publ.) Agrees to Advance Feasibility Study with Amorphox
CI
Transcript : Orexo AB, 2023 Earnings Call, Feb 08, 2024
Orexo Interim Report Q4 2023, incl. Full Year Report
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ORX Stock
  4. News Orexo AB